DUBLIN, September 28, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global RFID Blood Monitoring Systems Market 2016-2020" report to their offering.
The analysts forecast the global RFID blood monitoring systems market to grow at a CAGR of 22.96% during the period 2016-2020.
Global RFID Blood Monitoring Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Growing adoption of RFID-based solutions for efficient blood monitoring is an important trend gaining traction in the market. The industry has been witnessing a growing use of RFID-based solutions to improve efficiency. For instance, in May 2016, Aegis Sciences Corporation employed an RFID-based solution to monitor the status of blood and urine samples. In May 2016, the University of Tennessee Medical Centre also expanded its use of RFID within its 36 operating rooms. In March 2016, NSW Health Pathology that operates five clinical and scientific networks, deployed RFID technology at a blood bank it runs at the Liverpool Hospital, Sydney, Australia. It will allow the hospital to track blood products throughout the process of the supply chain. The increasing adoption of RFID technology for blood monitoring will fuel the market growth.
According to the report, robust guidelines enabling use of RFID for blood monitoring is a key driver contributing to this market's growth. The International Society of Blood Transfusion (ISBT) Working Party on Information Technology voted in 2006 to form a task force on RFID to review the state of RFID development and recommend guidelines for the application of RFID in transfusion medicine. The guidelines cover the use of RFID in the blood product supply chain from bag manufacturing to the donor and the individual.
Further, the report states that high initial investment and maintenance cost is a major challenge this market is facing. The high initial costs of RFID systems have restricted adoption of these devices. The start-up costs of RFID implementation in an 800-bed hospital will be in the range of $20,000 to $1 million, depending on the requirement. Also, according to the College of American Pathologists, RFID tags were 10-15 times more expensive than barcode systems. A passive tag costs between $0.1 (10 cents) and $0.5 (50 cents), while active tags are priced between 50 cents and $50. This has resulted in the slow adoption of RFID in blood monitoring. Another reason for slow adoption of RFID in hospitals is high maintenance costs. These factors will have a significant impact on the growth of the market.
Mediware Information Systems
Other prominent vendors
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Blood bank funding and financial stability
Part 06: Harmonization of biobanking/blood banking
Part 07: Market landscape
Part 08: Market segmentation by product type
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/jvxnt7/global_rfid_blood
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
For more information:
Last updated on: 28/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.